October 13, 2016
SpineGuard Reports €1.7M Revenue for 3Q 2016, and 9 Months Growth of 15%
SpineGuard announced today that its third quarter revenue grew to €1.7 million, a 2% increase compared with 3Q 2015.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
October 13, 2016
Adocia Announces Third Quarter 2016 Financial Results
Adocia a clinical stage biopharmaceutical company announced today third quarter revenue and net cash position ending September 30,2016.
October 13, 2016
Mauna Kea Technologies: Study of Cellvizio for Pediatric Cardiac Surgery
Mauna Kea Technologies inventor of Cellvizio, the multidisciplinary confocal laser endomicroscopy platform, announced today the launch of a ground-breaking new clinical study led by researchers at the University of Utah School of Medicine and Harvard Medical School called: “Evaluation of Fiberoptic Confocal Microscopy for Pediatric Cardiac Surgery.”
October 12, 2016
Bayer closed syndication of USD 56.9 billion acquisition facilities
Bayer has announced that the acquisition facilities of USD 56.9 billion that Bayer had agreed with five underwriter banks (BofA Merrill Lynch, Credit Suisse, Goldman Sachs, HSBC and JP Morgan) prior to announcement of the Monsanto acquisition has now been successfully syndicated within the group of Bayer’s core relationship banks.
October 12, 2016
October 12 – World Arthritis Day
Arthritis is very common but is not well understood. Actually, “arthritis” is not a single disease; it is an informal way of referring to joint pain or joint disease.
October 12, 2016
Pharmaceutical daily wishes you happy and healthy holidays!!!
Pharmaceutical daily brings daily pharmaceutical news from all around the world. We scoop for information about clinical research, new products in…
October 12, 2016
Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”
Hikma Pharmaceuticals has announced that Said Darwazah, Chairman and Chief Executive Officer of Hikma, received the “Leader of the Year Award” at the Global Generics and Biosimilars Awards held in Barcelona on 4 October 2016.
October 12, 2016
Inspirational Portraits And Interviews Of Famous Women in Allergan’s ActuallySheCan campaign
ActuallySheCanSM, the female empowerment campaign by Allergan, has unveiled a striking series of portraits shot by celebrated photographers Inez van…
October 12, 2016
Ablynx, Merck further extend their collaboration on ion channel research, Ablynx gets €1M
Ablynx has extended for a second time its research collaboration with a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, known as MSD outside the United States and Canada, to develop and commercialise Nanobody candidates directed towards an undisclosed voltage gated ion channel.
October 11, 2016
ESMO 2016: Single-Arm Trials Improve Early Access to Rare Cancer Drugs
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer drugs, single-arm trials (SATs) can provide invaluable opportunities to speed up cancer drug development and approval, in particular for drugs with dramatic activity and strong biological rationale in small populations with high unmet need, Dr. Jorge Martinalbo, Scientific Officer at the European Medicines Agency (EMA) reported at the ESMO 2016 Congress.